Enterprise AI, in production.
    Four desks, one beat.

    PharmaNews

    Tetsuwan Scientific Secures $2.7M to Develop AI Scientists That Will Transform Research and Speed Up Discoveries

    As these AI systems evolve, they will become far more than tools for repetitive tasks—they will become true collaborators in scientific discovery.

    Last updated

    Tetsuwan Scientific Secures $2.7M to Develop AI Scientists That Will Transform Research and Speed Up Discoveries

    As children, the founders of Tetsuwan Scientific, Cristian Ponce and Theo Schafer, were captivated by Astro Boy, a show about a robotic child who used his advanced intellect and compassion to protect humanity from danger. In Japan, the show is known as Tetsuwan Atom, and its legacy was one of the first glimpses into a world where machines could think and act alongside humans. Inspired by this sense of wonder, both Ponce and Schafer pursued careers in science and technology, attending prestigious institutions such as Caltech, ETH Zurich, and MIT. It was here that they nurtured a shared vision: a future where technology not only augmented human potential but redefined it. That vision is now coming to life through Tetsuwan Scientific, a cutting-edge startup that is harnessing the power of robotics and AI to accelerate scientific discovery.

    Founded in 2023, Tetsuwan Scientific is on a mission to automate the scientific method itself. Through the development of fully autonomous AI-powered "scientists," the company aims to revolutionize how experiments are conducted, speeding up the pace of discovery and making it more reproducible. In the short term, these AI scientists will serve as advanced assistants to human researchers, able to conduct complex experiments with a level of precision and scalability previously thought unattainable. This breakthrough has the potential to transform industries like cancer therapeutics, precision medicine, and drug discovery.

    The long-term impact of Tetsuwan's AI scientists, however, is even more profound. The company envisions a future where AI scientists not only assist in experiments but independently set and pursue their own scientific goals. This would mean AI capable of creating hypotheses, designing experiments, and executing discoveries without human intervention. If successful, this development could automate the scientific method entirely, accelerating progress in a way that could lead to exponential growth in human knowledge, with far-reaching consequences for global health, technology, and society.

    Tetsuwan’s Breakthrough and Funding Success

    To bring this ambitious vision to life, Tetsuwan has raised an oversubscribed $2.7 million pre-seed funding round, led by 2048 Ventures. The round also saw participation from Carbon Silicon, Everywhere Ventures, and prominent angel investors such as Sonia Arrison from the Foresight Institute and Eduardo Torrealba of Formlabs. This influx of capital is crucial for Tetsuwan’s efforts to advance its autonomous AI systems, with the company already deploying its first AI-powered robot in a rare disease gene therapeutics lab.

    by AIM Media HouseFree · No paywall

    Keep reading. It's free.

    Create a free Deployed account to finish this story and every story on the site. Choose the briefings you want with it:

    or

    No credit card. One click to unsubscribe. Already a reader? Sign in

    About the author

    Anshika Mathews

    Anshika is the Global Media Lead for AIM Media House. She holds a keen interest in technology and related policy-making and its impact on society.

    Related stories